DKA and HHS

90
A&E(VINAYAKA) Diabetic Ketoacidosis Hyperglycemic Hyperosmolar State Dr. Soumar Dutta PG Trainee Accident and Critical Care Medicine

Transcript of DKA and HHS

Page 1: DKA and HHS

A&E(VINAYAKA)

Diabetic KetoacidosisHyperglycemic Hyperosmolar

State

Dr. Soumar DuttaPG Trainee

Accident and Critical Care Medicine

Page 2: DKA and HHS

A&E(VINAYAKA)

Diabetic KetoacidosisDiabetic Ketoacidosis

Page 3: DKA and HHS

A&E(VINAYAKA)

IntroductionIntroduction

ā€¢ Acute life threatening complication of DM

ā€¢ DKA predominantly seen in type 1 DM

ā€¢ DKA represents bodyā€™s response to cellular starvation due to insulin deficiency & counter regulatory hormone excess

Page 4: DKA and HHS

A&E(VINAYAKA)

DKADKA

Page 5: DKA and HHS

A&E(VINAYAKA)

ClassificationClassification

Mild DKA Moderate DKA Severe DKA

Plasma glucose > 250 mg/dl > 250 mg/dl > 250 mg/dl

Arterial ph 7.25-7.30 7.0-7.24 < 7.0

Serum bicarbonate 15-18 10-<15 < 10

Urine ketones + + +Anion gap >10 >12 >12

Alteration in sensorium alert alert/drowsy stupor/coma

Page 6: DKA and HHS

A&E(VINAYAKA)

Pathophysiology of DKA Pathophysiology of DKA

Page 7: DKA and HHS

A&E(VINAYAKA)

ā€¢ Facilitate uptake of glucose & conversion into glycogenā€¢ Inhibits glycogenolysis & gluconeogenesis

ā€¢ Increase lipogenesisā€¢ Inhibit lipolysis

ā€¢ Uptake of amino acids into muscle cellā€¢ Prevents release of amino acids from muscle

Page 8: DKA and HHS

A&E(VINAYAKA)

PathophysiologyInsulin Deficiency is the primary defect in patients with DKA

Muscle Hepatocyte Adipose

Glucose

AminoAcids

Glucose-P

Glycogen

Pyruvate, CO2

Glucose

FreefattyacidsKetoacids

Normal Insulin Activity

Page 9: DKA and HHS

A&E(VINAYAKA)

Pathophysiology

Insulin

GlucagonEpinephrine

CortisolGrowth Hormone

Page 10: DKA and HHS

A&E(VINAYAKA)

Pathophysiology

Decreased Glucose UtilizationLipolysis

Insulin

GlucagonEpinephrine

CortisolGrowth Hormone

Page 11: DKA and HHS

A&E(VINAYAKA)

DKA - EarlyDKA - Early

ā€¢ Relative Insulin Deficiencyā€¢ Glycogenolysis & gluconeogenesisā€¢ Peripheral glucose uptake

Elevates blood glucose

Decreased Utilization post-prandial

and Stress-Induced

hyperglycemia

Page 12: DKA and HHS

A&E(VINAYAKA)

Pathophysiology

GluconeogenesisGlycogenolysis

LipolysisKetogenesis

InsulinGlucagon

EpinephrineCortisol

Growth Hormone

Page 13: DKA and HHS

A&E(VINAYAKA)

ā€¢ Insulin Deficiency

GlycogenolysisGluconeogenesisHepatic glucose outputLipolysis: Release FFA -> liver VLDL & ketones Ketonemia and hyper TG

Acidosis , Hyperglycemia & Osmotic diuresis

DKA - LateDKA - Late Increased Production &Decreased Utilization Fasting hyperglycemia

Page 14: DKA and HHS

A&E(VINAYAKA)

Page 15: DKA and HHS

A&E(VINAYAKA)

Islets of Langerhans

-cell destruction Insulin Deficiency

Adipo-cytes

Muscle

Liver

Decreased Glucose Utilization &Increased Production

GlucagonIncreasedProtein

CatabolismIncreasedKetogenesisGlucoaneogenesis,Glycogenolysis

IncreasedLipolysis

HyperglycemiaKetoacidosis

HyperTG

PolyuriaVolume Depletion

Ketonuria

AminoAcids

FattyAcids

StressEpi,Cortisol

GH,Glucagon

Threshold180 mg/dl

Page 16: DKA and HHS

A&E(VINAYAKA)

Page 17: DKA and HHS

A&E(VINAYAKA)

Precipitating factors of DKAPrecipitating factors of DKA

ā€¢ Omission or reduced daily insulin injectionā€¢ Infectionā€¢ Pancreatitisā€¢ Myocardial Infarctionā€¢ Mesentric Ischemiaā€¢ Renal Insufficeincyā€¢ CVA

ā€¢ Pulmonary embolismā€¢ G I hemorrhageā€¢ Heat related illnessā€¢ Parenteral/enteral

alimentationā€¢ Rhabdomyolysisā€¢ Severe Burns

Page 18: DKA and HHS

A&E(VINAYAKA)

Drugs Precipitate DKADrugs Precipitate DKA

ā€¢ Diureticsā€¢ Lithiumā€¢ Beta Blockersā€¢ Mannitolā€¢ Chlorpromazineā€¢ Cimetidine

ā€¢ Glucocorticoidsā€¢ Neurolepticsā€¢ Phenytoinā€¢ Didanosineā€¢ Calcium-channel

blockersā€¢ Pentamidine

Page 19: DKA and HHS

A&E(VINAYAKA)

Clinical featuresClinical features

Hyperglycemia

Osmotic diuresis and renal loss of Na, K, PO4, Ca and Mg

Hypovolemia,acidosis and hyperventilation

Page 20: DKA and HHS

A&E(VINAYAKA)

Clinical featuresClinical features

ā€¢ Increased PGI2 and PGE2peripheral vasodilation ,nausea, vomiting and abdominal pain.

ā€¢ Vomiting maladaptive response to counter acidosis exacerbates the potassium losses

Page 21: DKA and HHS

A&E(VINAYAKA)

Signs of DKASigns of DKA

ā€¢ Dehydrationā€¢ Hyperventilationā€¢ Ketotic breathā€¢ Tachycardia and hypotensionā€¢ Disturbed conscious state and shock

ā€¢ Alteration of consciousness correlate better with elevated serum osmolality (>320 mOsm/L) than with severity of metabolic acidosis

Page 22: DKA and HHS

A&E(VINAYAKA)

SymptomsSymptoms

ā€¢ Polyuria

ā€¢ Polydipsia

ā€¢ Nausea and vomiting

ā€¢ Abdominal Pain

ā€¢ Breathing difficulty

Page 23: DKA and HHS

A&E(VINAYAKA)

Lab InvestigationsLab Investigations

ā€¢ Serum glucoseā€¢ Serum electrolytesā€¢ Complete blood countā€¢ Renal function testā€¢ Serum & urine ketonesā€¢ Blood gas analysis

Page 24: DKA and HHS

A&E(VINAYAKA)

Lab InvestigationsLab Investigations

ā€¢ Blood culturesā€¢ Sputum collection ā€¢ Urine analysis & Cultureā€¢ Liver function tests & Coagulation profiileā€¢ Cardiac enzymesā€¢ Thyroid function testsā€¢ Toxicological Screening

Page 25: DKA and HHS

A&E(VINAYAKA)

RadiologyRadiology

ā€¢ Chest X ray

ā€¢ ECG

ā€¢ USG Abdomen

ā€¢ CT Head

ā€¢ Lumbar Puncture

Page 26: DKA and HHS

A&E(VINAYAKA)

Corrected SodiumCorrected Sodium

Measured Na + 1.6 (Glucose-100)

100ā€¢Na+ depressed 1.6 mEq/L per 100 mg% glucose rise above 100 mg/dl.

Page 27: DKA and HHS

A&E(VINAYAKA)

Corrected SodiumCorrected Sodium

Example:Na+ = 123 meq/L and Glucose = 1,250 mg/dl

Measured Na + 1.6 (Glucose-100) 100

= 123 + 1.6 (1250-100) 100Corrected Na+ = 123 + 18 = 141 meq/L

Page 28: DKA and HHS

A&E(VINAYAKA)

Serum OsmolaritySerum Osmolarity

2(Na) + Glucose + BUN 18 2.8

Page 29: DKA and HHS

A&E(VINAYAKA)

D/D

Page 30: DKA and HHS

A&E(VINAYAKA)

Management of DKAManagement of DKA

Page 31: DKA and HHS

A&E(VINAYAKA)

Goals of TreatmentGoals of Treatment

ā€¢ Volume Repletionā€¢ Reversal of metabolic consequences of

insulin insufficiencyā€¢ Correction of acid-base & electrolyte

imbalancesā€¢ Recognition & Treatment of precipitating

causesā€¢ Avoidance of complications

Page 32: DKA and HHS

A&E(VINAYAKA)

Management of DKAManagement of DKA

Page 33: DKA and HHS

A&E(VINAYAKA)

Approach to therapyApproach to therapy

ā€¢ Correcting the hyperosmolar state and dehydration is the initial aim of therapy.

ā€¢ Insulin therapy should be undertaken only after the patient is stable hemodynamically.

Glucose and H2O

H2O lost in urine Loss of ECF, vascular collapse and death

Page 34: DKA and HHS

A&E(VINAYAKA)

Fluid ResuscitationFluid Resuscitation

ā€¢ Single most important stepā€¢ Fluid deficit around 100ml/kg (5-10L)ā€¢ Helps in Restore I/V volumeā€¢ Perfuse vital organsā€¢ Increase GFRā€¢ Decrease serum Glucose & Ketone levelsā€¢ To restore normal tonicity

Page 35: DKA and HHS

A&E(VINAYAKA)

Fluid balance in diabeticFluid balance in diabetichyperosmolarityhyperosmolarity

ECF = 14 L ICF = 28 L

H2O

ECF ICF

H2O

Osmotic Diuresis

Osmotic Diuresis ECF hyperosmolar from ICF autotransfusion

ECF and ICF both hyperosmolar

Page 36: DKA and HHS

A&E(VINAYAKA)

Fluid ResuscitationFluid Resuscitation

ā€¢ NS most frequently administered fluidā€¢ 1 litre in 30 minā€¢ 2 litres in 2 hoursā€¢ 2 litres in 2-6 hoursā€¢ 2 litres in 6-12 hours

Page 37: DKA and HHS

A&E(VINAYAKA)

Page 38: DKA and HHS

A&E(VINAYAKA)

Fluid ResuscitationFluid Resuscitation

ā€¢ 2ā€“3 L of 0.9% saline over first 1ā€“3 h (10ā€“15 mL/kg per hour)

ā€¢ 0.45% saline at 150ā€“300 mL/h; change to 5% glucose and 0.45% saline at 100ā€“200 mL/h when plasma glucose reaches 250 mg/dl.

Page 39: DKA and HHS

A&E(VINAYAKA)

Fluid ResuscitationFluid Resuscitation

ā€¢CVP guided fluids should be considered for elderly & those with heart disease

ā€¢Excess fluid may lead to ARDS & cerebral edema

Page 40: DKA and HHS

A&E(VINAYAKA)

Insulin therapyInsulin therapy

Mechanism of Action:

ā€¢ Inhibit gluconeogenesis, lipolysis, catabolic

hormone secretion, production of ketoacids

ā€¢ Promote potassium, glucose & phosphate

uptake in tissues

Page 41: DKA and HHS

A&E(VINAYAKA)

Insulin therapyInsulin therapy

ā€¢ Ideal way to administer insulin by continuous infusion of small doses of regular insulin 0.1unit/kg/hr once hypokalemia is excluded.

ā€¢ I/M or S/C administration of regular insulin should be avoided as insulin absorption may be erratic in volume depleted & vasocostricted patient

Page 42: DKA and HHS

A&E(VINAYAKA)

Insulin therapyInsulin therapy

ā€¢ Goal is to decrease Glucose by 50-75mg/dl/hr.50-75mg/dl/hr.

ā€¢ Infusion should continue until anion gap normalized

ā€¢ S/C insulin should bridge for atleast one hour before discontinuation of I/V insulin

ā€¢ Insulin administration should be W/H if K <3.3 mEq till K is supplemented

Page 43: DKA and HHS

A&E(VINAYAKA)

DKA: Switch to S.C. insulinDKA: Switch to S.C. insulin

Can consider switch to SC insulin when:

ā€¢ AG normalizedā€¢ BS < 250 mg/dlā€¢ Insulin IV requirements < 2U/hā€¢ Patient able to eatā€¢ Hemodynamically stable

Page 44: DKA and HHS

A&E(VINAYAKA)

DKA: Switch to S.C. insulinDKA: Switch to S.C. insulin

ā€¢ Overlap insulin IV with 1st SC insulin by 2-4h to avoid recurrent ketosis

ā€¢ T2 DM patients with DKA:ā€¢ Donā€™t necessarily have to be continued on

insulinā€¢ Once acute stress resolved, many do well on

OHA

Page 45: DKA and HHS

A&E(VINAYAKA)

Potassium CorrectionPotassium Correctionā€¢ K+ defecit: 3-5 mEq/Kg (350 mEq for 70Kg)ā€¢ Normal to high serum K+

K+ K+H+ H+

Ketoacidosis

Insulin

Page 46: DKA and HHS

A&E(VINAYAKA)

Potassium CorrectionPotassium Correction

ā€¢ Deficiency is due to

ā€¢ Decreased insulin levelsā€¢ Metabolic Acidosisā€¢ Osmotic Diuresisā€¢ Frequent Vomitting

Page 47: DKA and HHS

A&E(VINAYAKA)

Goal of K ReplacementGoal of K Replacement

ā€¢ To maintain a normal extracellular K+ conc during

the acute phase of therapy and to replace intra-

cellular deficits over a period of days

Page 48: DKA and HHS

A&E(VINAYAKA)

K SupplementationK Supplementation

Serum Potassium < 3 mEq/L Give 60mEq/l to IVF

3-3.9 mEq/L 40mEq/l to IVF

4-5.4 mEq/L 20 mEq/L to IVF

> 5.5 mEq/L No Replacement necessary

Verify Normal kidney function & Urine output before treatment

Page 49: DKA and HHS

A&E(VINAYAKA)

BicarbonateBicarbonate

ā€¢ Routine use of supplemental bicarbonate in

Rx of DKA is not recommended

ā€¢ Can be given if PH Is less than 6.9

Page 50: DKA and HHS

A&E(VINAYAKA)

ADA RecommendationADA Recommendation

If PH 6.9-7.0 50mEq of NaHCo3+200ml sterile water+10mEq KCl over 1 hour

If Ph <6.9 100mEq of NaHCo3+400ml sterile water+10mEq KCl over 2 hours

Repeat dose of bicarb every 2 hours till PH>7

Page 51: DKA and HHS

A&E(VINAYAKA)

Theoretical AdvantagesTheoretical Advantages

ā€¢ In case of severe acidosis

ā€¢ Improve myocardial contractility

ā€¢ Improve catecholamine tissue response

ā€¢ Decrease work of breathing

ā€¢ In case of Hyperkalemia

ā€¢ Elevate ventricular fibrillation threshold

Page 52: DKA and HHS

A&E(VINAYAKA)

DisadvantagesDisadvantages

ā€¢ Severe & worsening hypokalaemia

ā€¢ Paradoxical CNS acidosis

ā€¢ Impair oxyhemoglobin dissociation

ā€¢ Hypertonicity

ā€¢ Sodium overload

Page 53: DKA and HHS

A&E(VINAYAKA)

DisadvantagesDisadvantages

ā€¢ Delayed recovery from ketosis

ā€¢ Elevation of lactic levels

ā€¢ Precipitation of cerebral edema / Pulmonary

edema

ā€¢ Thrombophlebitis

ā€¢ Require Central venous cannulation

Page 54: DKA and HHS

A&E(VINAYAKA)

HypophosphatemiaHypophosphatemia

ā€¢ Most severe 24-48 hours after treatmentā€¢ Treatment If Levels <1.0 mg/dlā€¢ C/F

ā€¢ Hypoxiaā€¢ Rhabdomyolysisā€¢ Hemolysisā€¢ Respiratory failureā€¢ Cardiac Dysfunction

Page 55: DKA and HHS

A&E(VINAYAKA)

HypophosphatemiaHypophosphatemia

ā€¢ IV (K2PO4 ) : 1ml/hr. (4.4 mEq potassium + 93 mg

phosphate )

ā€¢ S/Eā€¢ Hyperphosphatemiaā€¢ Hypocalcemiaā€¢ Hypomagnesemiaā€¢ Metastatic soft tissue calcificationā€¢ Hypernatremiaā€¢ Osmotic diuresis

Page 56: DKA and HHS

A&E(VINAYAKA)

HypomagnesemiaHypomagnesemia

ā€¢ Inhibit parathyroid hormone secretionā€¢ hypocalcaemia & hyper phosphatemia

ā€¢ Supplementation if Mg <1.2 mg/dl

ā€¢ Can give Oral Magnesium oxide orā€¢ Parenteral Magnesium sulphate

Page 57: DKA and HHS

A&E(VINAYAKA)

Monitoring Monitoring

ā€¢ Periodical assessment of vital signs

ā€¢ Level of consciousness

ā€¢ Hourly urine output

ā€¢ Serum glucose Q1H

ā€¢ Serum Potassium Q2H

ā€¢ Regular assessment of anion gap

Page 58: DKA and HHS

A&E(VINAYAKA)

Complications of DKA Complications of DKA

Page 59: DKA and HHS

A&E(VINAYAKA)

DKA in PediatricsDKA in Pediatrics

Page 60: DKA and HHS

A&E(VINAYAKA)

Criteria for diagnosisCriteria for diagnosis

ā€¢ Hyperglycemia: CBG > 300mg/dl.

ā€¢ Metabolic acidosis:pH < 7.25 ā€“ 7.30

HCO3- < 15 mEq/L

ā€¢ Ketonemia

Page 61: DKA and HHS

A&E(VINAYAKA)

Clinical featuresClinical features

ā€¢ Polyuriaā€¢ Polydipsiaā€¢ Polyphagiaā€¢ Abdominal painā€¢ Nausea and vomitingā€¢ Rapid weight lossā€¢ Fatigue

ā€¢ Confusionā€¢ Visual changes

Page 62: DKA and HHS

A&E(VINAYAKA)

SignsSigns

ā€¢ Dehydrationā€¢ Tachycardiaā€¢ Hypotensionā€¢ Kussmaul respiration (rapid & deep)ā€¢ Sweet, fruity odour on the breath ā€¢ LOC/Coma (look for cerebral edema)

Page 63: DKA and HHS

A&E(VINAYAKA)

Treatment goalsTreatment goals

ā€¢ Establish good perfusion statusā€¢ Reverse the acidosisā€¢ Correct electrolyte disturbancesā€¢ Control hyperglycemia ā€¢ Ketonemia

Page 64: DKA and HHS

A&E(VINAYAKA)

TreatmentTreatment

Page 65: DKA and HHS

A&E(VINAYAKA)

Correction of acidosisCorrection of acidosis

Donā€™t use bicarbonate asā€¢ It will increase chances of cerebral edema

by 4 times.ā€¢ can lead to volume overload,

hypernatremia, paradoxical cerebral acidosis, accelerated K+ loss

Is there any role for bicarbonate in DKA?

Page 66: DKA and HHS

A&E(VINAYAKA)

Indication for bicarbonateIndication for bicarbonate

ā€¢ pH < 7.0ā€¢ Hemodynamically unstableā€¢ Not responding to fluidsā€¢ Depressed cardiac contractiltyā€¢ Poor perfusion

Dose: 0.5 ā€“ 2 mEq/kg over 1-2 hrs

Stop correction once pH >7.0

Page 67: DKA and HHS

A&E(VINAYAKA)

Major complication of DKAMajor complication of DKA

ā€¢ Cerebral Edema: most dreaded complicationā€¢ 57-87% of all pediatric DKA-

associated deathsā€¢ More in < 5yrs Rare in > 20 yrs.

Page 68: DKA and HHS

A&E(VINAYAKA)

Reasons for Cerebral EdemaReasons for Cerebral Edema

ā€¢ Over aggressive fluid correctionā€¢ Failure of Na+ to rise with fall of glucose

during treatmentā€¢ Cerebral ischemia due to severe dehydration

and hypocarbia

Onset : 6-12 hrs. after onset of therapy

Page 69: DKA and HHS

A&E(VINAYAKA)

Clinical features Clinical features

ā€¢ Severe headacheā€¢ Seizuresā€¢ Papilledemaā€¢ Respiratory arrestā€¢ Altered mental status

Page 70: DKA and HHS

A&E(VINAYAKA)

Page 71: DKA and HHS

A&E(VINAYAKA)

Hyperglycemia Hyperosmolar State (HHS)

Page 72: DKA and HHS

A&E(VINAYAKA)

IntroductionIntroduction

ā€¢ A metabolic emergency that occurs in diabetic patient usually Type 2 Diabetes Mellitus

ā€¢ Characterised by uncontrolled hyperglycemia that induces hyperosmolar state and dehydration without significant ketoacidosis.

Page 73: DKA and HHS

A&E(VINAYAKA)

Diagnostic featuresDiagnostic features

ā€¢ Plasma glucose level of 600 mg/dL or greater

ā€¢ Effective serum osmolality of 320 mOsm/kg or greater

ā€¢ Profound dehydration (8-12 L) with elevated serum urea nitrogen (BUN)-to-creatinine ratio

Page 74: DKA and HHS

A&E(VINAYAKA)

Diagnostic featuresDiagnostic features

ā€¢ Small ketonuria and absent-to-low ketonemia

ā€¢ Bicarbonate concentration greater than 15 mEq/L

ā€¢ Some alteration in consciousness

Page 75: DKA and HHS

A&E(VINAYAKA)

DKA Vs. HHSDKA Vs. HHSDKA HHS

Glucose 250-600 >600

Sodium 125-135 135-145

Potassium Normal/inc Normal

Bicarbonate <15meq/l Normal/slightly reduced

Arterial pH <7.3 >7.3

Anion gap Increased Normal/slightly increased

pCO2 20-30 Normal

Osmolality 300-320 >320

Page 76: DKA and HHS

A&E(VINAYAKA)

CausesCauses

ā€¢ Dehydrationā€¢ Pneumonia and UTIā€¢ Counter-regulotary

hormone (e.g cortisol, cathecolamine, glucagon)

ā€¢ Dialysisā€¢ TPNā€¢ Non-compliance to OHA

or insulin therapy

Drugsā€¢ Diureticsā€¢ B-blockerā€¢ Histamine(H2)

Blockerā€¢ Anti-psychotics

Clozapine, Olanzapine

ā€¢ Alcohol and cocaine

Page 77: DKA and HHS

A&E(VINAYAKA)

PathophysiologyPathophysiologyConcomitant illness

Circulating insulin& of counter-regulatory hormones

renal clearance and peripheral utilization of glucose

Hyperglycemia Osmotic diuresis

Loss of electrocyte and water

Dehydration

Hyperosmolarity Intracellular dehydration

Page 78: DKA and HHS

A&E(VINAYAKA)

Clinical featuresā€¢ Occurs only in type 2 DM

ā€¢ Could be initial presentation of the diabetic state

ā€¢ Elderly

ā€¢ Obtundation to coma

Page 79: DKA and HHS

A&E(VINAYAKA)

Clinical featuresā€¢ Severe dehydration invariable

ā€¢ May have associated lactic acidosis due to hypoxia

ā€¢ Precipitating factors similar to DKA

ā€¢ Mortality rate is high

Page 80: DKA and HHS

A&E(VINAYAKA)

SymptomsSymptoms

Symptoms of hyperglycemia :PolydipsiaPolyuriaLethargic

Others :Weight lossLoss of consciousness

Page 81: DKA and HHS

A&E(VINAYAKA)

SymptomsSymptoms

A wide variety of focal and global neurologic changes may be present :

ā€¢ Drowsiness and lethargyā€¢ Deliriumā€¢ Comaā€¢ Focal or generalized seizuresā€¢ Visual changes or disturbancesā€¢ Hemiparesisā€¢ Sensory deficits

Page 82: DKA and HHS

A&E(VINAYAKA)

Physical examination Physical examination

Dehydrated : dry skin, lips, mucous membrane, loss skin turgor

Vital sign : tachycardia (early dehydration), hypotension (later), temperature

Systemic examination to ruled out the cause.

Page 83: DKA and HHS

A&E(VINAYAKA)

Differential diagnosisDifferential diagnosis

ā€¢ Alcoholic ketoacidosisā€¢ Delirium (altered mentation)ā€¢ Dementiaā€¢ Overdoseā€¢ Thyrotoxicosis (tachycardia, fever,

dehydration)

Page 84: DKA and HHS

A&E(VINAYAKA)

Lab studiesLab studiesā€¢ Plasma glucose

Hyperglycemia: CBG : > 600 mg/dlā€¢ ABG

PH> 7.3HCO3>15 mmol/l

ā€¢ Serum osmolality>320 mmol/l

Page 85: DKA and HHS

A&E(VINAYAKA)

OthersOthers

ā€¢ Urine-analysisā€¢ Exclude UTIā€¢ Proteinuria

ā€¢ Plasma ketoneā€¢ Plasma electrolyteā€¢ Renal function test( Creatinine &BUN)ā€¢ CBCā€¢ Creatine kinase

Page 86: DKA and HHS

A&E(VINAYAKA)

Imaging studiesImaging studies

Chest radiographā€¢ Exclude pnuemoniaā€¢ Cardiomegaly

CT scan of the headā€¢ Exclude haemorrhagic stroke, subdural

haematomaā€¢ Look for cerebral edema

Page 87: DKA and HHS

A&E(VINAYAKA)

ManagementManagement

Treatment Goals:

ā€¢ Correction of hypovolemiaā€¢ Identify and treating underlying causeā€¢ Correcting electrolyte abnormalitiesā€¢ Gradual correction of hyperglycemia and

osmolarityā€¢ Frequent monitoring

Page 88: DKA and HHS

A&E(VINAYAKA)

ManagementManagement

Page 89: DKA and HHS

A&E(VINAYAKA)

References

Page 90: DKA and HHS

A&E(VINAYAKA)

Thank You